Similar to brachytherapy, OncoPatch could be an option for patients who have superficial lesions or who aren’t surgical candidates.

Skin cancer is the most common type of cancer in the United States. For most people, surgery is the recommended choice for treatment. But there is another option that doesn’t involve surgery. It’s ...

Editor’s note: This column is in response to one written by Dr. Daniel Shurman that appeared in the Sept. 22 edition of the Reading Eagle. As physician members of the Dermatology Association of ...

OncoPatch announced today that it received FDA 510(k) for its Oncopatch Surface brachytherapy system for treating localized tumors.

Oncopatch represents a meaningful addition to the treatment landscape for skin cancer…particularly in situations where ...

Brussels, 17 July 2025 – Today marks Brachytherapy Awareness Day, a global initiative to spotlight a cancer treatment that is saving lives with precision: brachytherapy. This advanced form of internal ...